Jove
Visualize
Contact Us

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<b>B</b>ea<b>r</b>berry in the treatment of acute unco<b>m</b>pl<b>i</b>cated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial.

BMJ open·2022
Same author

Quality Standards for Herbal Drugs and Herbal Drug Preparations - Appropriate or Improvements Necessary?

Planta medica·2017
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

[The HMPC monograph on Hypericum: Background, development, contents].

Reinhard Länger1

  • 1Abteilung Pflanzliche Arzneimittel und Homöopathika, AGES PharmMed, Wien, Austria. reinhard.laenger@ages.at

Wiener Medizinische Wochenschrift (1946)
|December 21, 2010
PubMed
Summary

The EU monograph on Hypericum advances herbal medicine harmonization. Clinical data support its efficacy for mild depression and relapse prevention, with specific usage guidelines for safety.

More Related Videos

Field Identification of Matricaria chamomilla using a Portable qPCR System
12:08

Field Identification of Matricaria chamomilla using a Portable qPCR System

Published on: October 10, 2020

Related Experiment Videos

Last Updated: Jun 5, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Field Identification of Matricaria chamomilla using a Portable qPCR System
12:08

Field Identification of Matricaria chamomilla using a Portable qPCR System

Published on: October 10, 2020

Area of Science:

  • Pharmacognosy
  • Clinical Pharmacology
  • Regulatory Science

Context:

  • European Union (EU) herbal medicinal product harmonization.
  • EU community monograph on Hypericum (St. John's Wort).
  • Assessment of clinical data for herbal preparations.

Purpose:

  • To evaluate the efficacy and safety of Hypericum extracts for mild to moderate depressive episodes.
  • To establish guidelines for the use of Hypericum in traditional herbal medicinal products.
  • To harmonize the regulation of herbal medicinal products within the European Community.

Summary:

  • Clinical data support the efficacy of two Hypericum extracts in treating mild to moderate depression and preventing relapse.
  • Efficacy of other dry extracts in short-term treatment of mild depressive symptoms is substantiated.
  • Safety considerations include a two-week limit for oral administration due to potential cytochrome P450 enzyme activity, unless hyperforin intake is below 1 mg daily.
  • Cutaneous administration for minor skin inflammations and wound healing is also included.

Impact:

  • Establishes a harmonized regulatory framework for Hypericum-based herbal medicines in the EU.
  • Provides evidence-based guidelines for the clinical use of Hypericum in depression and dermatology.
  • Facilitates market access for standardized Hypericum preparations while ensuring patient safety through clear usage instructions and warnings.